Company · CIK 0001944885 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Apollomics Inc. · APLM
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 MForm 4/A → | Sep 24, 7:54 pm EDT | Yi-Kuei ChenChief Operating Officer, Director | 5,000 | — | — | 20,100 | — | |
| Sep 15, 2026 FMForm 4/A → | Sep 24, 7:49 pm EDT | Peter Kuan-How LinChief Financial Officer | 13,416 | $24.02 | $82,052 | 55,563 | — | |
| Sep 15, 2026 MForm 4/A → | Sep 24, 7:49 pm EDT | Hung Hsien YenDirector | 500 | — | — | 500 | — | |
| Sep 15, 2026 FMForm 4 → | Sep 17, 8:55 pm EDT | Peter Kuan-How LinChief Financial Officer, Director | 13,416 | $24.02 | $82,052 | 55,563 | — | amended |
| Sep 15, 2026 MForm 4 → | Sep 17, 8:49 pm EDT | Hong-Jung ChenDirector | 500 | — | — | 4,120 | — | |
| Sep 15, 2026 MForm 4 → | Sep 17, 8:48 pm EDT | Yi-Kuei ChenChief Operating Officer, Director | 5,000 | — | — | 20,100 | — | amended |
| Sep 15, 2026 MForm 4 → | Sep 17, 8:47 pm EDT | Hsien-Shu TsaiDirector | 500 | — | — | 2,000 | — | |
| Sep 15, 2026 MForm 4 → | Sep 17, 8:44 pm EDT | Hung Hsien YenDirector | 500 | — | — | 500 | — | amended |
| Sep 15, 2026 MForm 4 → | Sep 17, 8:38 pm EDT | Hung-Wen ChenChief Executive Officer, Director, 10% Owner | 5,000 | — | — | 423,334 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 14, 2026 AMForm 4/A → | Sep 24, 7:54 pm EDT | Yi-Kuei ChenChief Operating Officer, Director | 13,000 | — | — | 5,000 | — | |
| Sep 14, 2026 AMForm 4/A → | Sep 24, 7:49 pm EDT | Peter Kuan-How LinChief Financial Officer | 16,000 | — | — | 10,000 | — | |
| Sep 14, 2026 AMForm 4/A → | Sep 24, 7:49 pm EDT | Hung Hsien YenDirector | 2,500 | — | — | 500 | — | |
| Sep 14, 2026 AMForm 4 → | Sep 17, 8:55 pm EDT | Peter Kuan-How LinChief Financial Officer, Director | 16,000 | — | — | 10,000 | — | late amended |
| Sep 14, 2026 AMForm 4 → | Sep 17, 8:49 pm EDT | Hong-Jung ChenDirector | 2,500 | — | — | 500 | — | late |
| Sep 14, 2026 AMForm 4 → | Sep 17, 8:48 pm EDT | Yi-Kuei ChenChief Operating Officer, Director | 13,000 | — | — | 5,000 | — | late amended |
| Sep 14, 2026 AMForm 4 → | Sep 17, 8:47 pm EDT | Hsien-Shu TsaiDirector | 2,500 | — | — | 500 | — | late |
| Sep 14, 2026 AMForm 4 → | Sep 17, 8:44 pm EDT | Hung Hsien YenDirector | 2,500 | — | — | 500 | — | late amended |
| Sep 14, 2026 AForm 4 → | Sep 17, 8:42 pm EDT | Ya-Chi HuangDirector | 2,000 | — | — | 2,000 | — | late |
| Sep 14, 2026 AMForm 4 → | Sep 17, 8:38 pm EDT | Hung-Wen ChenChief Executive Officer, Director, 10% Owner | 13,000 | — | — | 5,000 | — | late |